Sartorius Stedim Biotech Annual Shareholders' Meeting
March 25, 2025 | 1:00 p.m. CET | Aubagne
The combined Annual General Shareholders' Meeting of Sartorius Stedim Biotech S.A. was held at the company's headquarters in Aubagne, France.
On this page, we provide all information and documents as well as access to the VOTACCES website via Uptevia.
If you assume that the documents available are incomplete, please contact us promptly at asm.ssb@sartorius.com.
VOTACCES Website
Live Webcast for Everyone Interested
Media Release | March 25, 2025
Resolutions of the Combined Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A.
Information and Documents
Please note that the English versions of these documents are for your convenience only. The original legally binding documents are available on the French website.
- CEO Presentation PDF | 1.4 MB
- Voting Results (French version only) PDF | 84.3 KB
- Report of the Shareholders' Meeting PDF | 40.2 KB
- 1.1 Notice of the meeting BALO (Avis de Réunion | English translation for information) PDF | 598.3 KB
- 1.1 Notice of the meeting BALO (Avis de Réunion | French version only) PDF | 711.2 KB
- 1.2 Avis de Convocation (french version only) PDF | 581.3 KB
- 1.3 Agenda PDF | 225.3 KB
- 1.4 Resolutions PDF | 408.5 KB
- 1.5 Report of the Board on the Resolutions PDF | 369.1 KB
- 1.6 Vote form PDF | 433.4 KB
- 1.7 Request of documents by a shareholder PDF | 77.0 KB
- 1.8 Shareholders´ guide PDF | 2.0 MB
- 2.1 Annual financial statements of Sartorius Stedim Biotech S.A. PDF | 289.4 KB
- 2.2 Consolidated financial statements of the Sartorius Stedim Biotech Group PDF | 962.2 KB
- 2.3 Group management report PDF | 5.1 MB
- 2.4 Management report of the Sartorius Stedim Biotech S.A. PDF | 259.7 KB
- 2.5 Corporate Governance Report 2024 PDF | 586.7 KB
- 2.6 Statutory auditors’ report on the financial statements of Sartorius Stedim Biotech S.A. for the financial year ended 31.12.2024 (in French) PDF | 830.0 KB
- 2.7 Statutory auditors’ report on the consolidated statements of Sartorius Stedim Biotech Group for the financial year ended 31.12.2024 (in French) PDF | 1.4 MB
- 2.8 Statutory auditors’ report on the information disclosed in accordance with article L. 225-38 of the French Commercial Code (in French) PDF | 506.3 KB
- 2.9 Statutory auditors' report on the issue of shares and share equivalents with or without preferential subscription rights (in French) PDF | 739.4 KB
- 2.10 Statutory auditors' report on the authorization to grant existing or future free shares (in French) PDF | 512.8 KB
- 2.11 Statutory auditors' report on the issue of ordinary shares and/or securities giving access to the Company's capital reserved for members of a company savings plan (plan d'épargne d'entreprise) (in French) PDF | 597.3 KB
- 2.12 Statutory auditors' report on the capital reduction (in French) PDF | 543.2 KB
- 2.13 Total number of shares and voting rights making up the issued capital PDF | 76.5 KB
